Nektar Therapeutics (NASDAQ:NKTR) Q2 2023 Earnings Call Transcript

Nektar Therapeutics (NASDAQ:NKTR) Q2 2023 Earnings Call Transcript August 8, 2023

Nektar Therapeutics misses on earnings expectations. Reported EPS is $-0.27 EPS, expectations were $0.3.

Operator: Good day and thank you for standing by. Welcome to the Nektar Therapeutics Second Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode. After the speaker’s presentation, there will be a question-and-answer session. [Operator Instructions] Please...